Tokyo, Dec. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059965) titled 'Multicenter Retrospective Observational Study on Treatment Outcomes of Chemotherapy Combined with Zolbetuximab for Unresectable Advanced or Recurrent Gastric Cancer' on Dec. 4.
Study Type:
Observational
Primary Sponsor:
Institute - Hokkaido Gastrointestinal Cancer Chemotherapy Study Group
Condition:
Condition - Unresectable advanced or recurrent gastric cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To clarify the adverse events and treatment outcomes of solutaximab combination therapy for unresectable advanced or recurrent gastric or gastroesophageal ...